ArticleJCI insight2023

PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells.

Ziyu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.